Mike Huckman, who covers drug companies for CNBC, writes Thursday that Bristol-Myers Squibb changed its earnings release after a number of media outlets reported that they missed analyst expectations.
“Posts Fourth Quarter and Full Year 2007 Non-GAAP EPS of $0.33 and $1.38 from Continuing Operations ($0.35 and $1.48, including Discontinued Operations), Exceeding Top End of Non-GAAP Guidance Range”
“(GAAP stands for Generally Accepted Accounting Principles.)
“As a result, several news outlets including CNBC, Dow Jones, Associated Press and MarketWatch reported that BMY missed the 34-cent consensus by one cent.
“Curiously, when I just went to the Bristol-Myers Squibb web site to take another look at the press release, at first the page came up as ‘inactive.’ Okay, that could be some kind of computer snafu. Then a few seconds later the press release was back up, but guess what? The line that led to the widespread ‘confusion’ is gone! Disappeared. You can check it out for yourself.“
Read more here. Anybody else had a company change its earnings release after it was already released?
PCWorld executive editor Gordon Mah Ung, a tireless journalist we once described as a founding father…
CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
View Comments